Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group.

Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12.

PMID:
21225239
[PubMed - indexed for MEDLINE]
2.

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7. Epub 2008 Sep 25.

PMID:
18823658
[PubMed - indexed for MEDLINE]
Free Article
3.

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9. Epub 2008 Sep 25.

PMID:
18823656
[PubMed - indexed for MEDLINE]
4.

Leptin might be a regulator of serum uric acid concentrations in humans.

Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N.

Jpn Heart J. 2003 Jul;44(4):527-36.

PMID:
12906034
[PubMed - indexed for MEDLINE]
Free Article
5.

Gastric emptying time in patients with primary hypothyroidism.

Kahraman H, Kaya N, Demirçali A, Bernay I, Tanyeri F.

Eur J Gastroenterol Hepatol. 1997 Sep;9(9):901-4.

PMID:
9355790
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk